哺乳類細胞発酵技術の世界市場レポート 2025年

哺乳類細胞発酵技術市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.7％で895億4,000万米ドルに成長します。予測期間の成長は、慢性疾患の有病率の増加、多国籍企業による投資の増加、慢性疾患の頻度の増加、高度なバイオプロセス技術の採用の増加、新規組換えタンパク質の研究開発への投資の増加、がん治療に対する需要の増加などに起因すると考えられます。予測期間における主な動向としては、細胞培養の技術進歩、バイオリアクター設計の技術進歩、次世代バイオプロセス技術の開発、マルチオミクスアプローチの統合、技術主導の自動化などが挙げられます。

生物製剤に対する需要の増加は、今後の哺乳類細胞発酵技術市場の成長を促進すると予想されます。生物製剤は、生物またはその構成要素に由来する医薬品であり、がん、自己免疫疾患、感染症などの疾患の治療に用いられることが多いです。生物製剤の需要拡大は、バイオテクノロジーの進歩、蔓延する慢性疾患の治療における有効性、規制当局の承認、研究開発への投資の増加によってもたらされています。哺乳類細胞発酵技術は、複雑な生物製剤を製造し、個別化された標的治療薬に対する需要の高まりに対応するために極めて重要です。そのスケーラビリティ、汎用性、高品質のタンパク質を生産する能力は、バイオ医薬品業界におけるイノベーションを促進します。例えば、国立医学図書館が2024年2月に報告したところによると、食品医薬品局（FDA）が2023年に承認した新薬は55品目で、うち29品目は新規化学物質（NCE）、25品目は新規生物学的製剤（NBE）であり、2022年の37品目に比べて50％増加しました。このため、生物製剤に対する需要の高まりが哺乳類細胞発酵技術市場の拡大を牽引しています。

哺乳類細胞発酵技術市場の主要企業は、市場での地位を強化するため、哺乳類細胞培養などの革新的ソリューションの開発に注力しています。哺乳類細胞培養は、治療用タンパク質、ワクチン、機能性細胞や組織アナログの生産を容易にするため、バイオ製造、調査、再生医療など様々な分野で不可欠なツールです。例えば、2024年6月、ドイツを拠点とするバイオテクノロジー企業Syntegon社は、Achema 2024で新しいモジュラー・バイオプロセシング・プラットフォーム（MBP）を発表しました。この最先端プラットフォームは、バイオ医薬品製造における主要課題に対処するために設計されています。MBPは、微生物や哺乳類の細胞培養、タンパク質、ペプチド、オリゴヌクレオチド、プラスミドDNA、組換えワクチンなど、さまざまなアプリケーションをサポートできる、柔軟性の高い、完全に統合された自動化ソリューションです。MBPのモジュール設計は、厳格な"made in Germany "基準を遵守し、高い機能性と品質を維持しながら、リードタイムとコストの削減を可能にします。さらに、このプラットフォームのプレハブ式クリーンルーム設計は、すべての周辺技術をクリーンルーム外に配置することで、効率を高め、メンテナンスを簡素化し、哺乳類細胞発酵技術市場における先進的なソリューションとなっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界哺乳類細胞発酵技術 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の哺乳類細胞発酵技術市場：成長率分析
• 世界の哺乳類細胞発酵技術市場の実績：規模と成長, 2019-2024
• 世界の哺乳類細胞発酵技術市場の予測：規模と成長, 2024-2029, 2034F
• 世界哺乳類細胞発酵技術総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の哺乳類細胞発酵技術市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• チャイニーズハムスター卵巣細胞発酵
• ヒト胎児腎細胞発酵
• ベビーハムスターの腎臓細胞発酵
• マウス骨髄腫細胞発酵
• その他のタイプ
• 世界の哺乳類細胞発酵技術市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノクローナル抗体
• 組み換えタンパク質
• ワクチン
• ホルモン
• 酵素
• その他の用途
• 世界の哺乳類細胞発酵技術市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオ医薬品企業
• 契約調査機関および契約開発製造機関
• 学術研究機関

第7章 地域別・国別分析

• 世界の哺乳類細胞発酵技術市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の哺乳類細胞発酵技術市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 哺乳類細胞発酵技術市場：競合情勢
• 哺乳類細胞発酵技術市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AGC Group
• Lonza Group Ltd.
• Boehringer Ingelheim GmbH
• Catalent Inc.
• Sartorius AG
• Samsung Biologics Co. Ltd.
• WuXi Biologics
• Biocon Limited
• Eppendorf AG
• KBI Biopharma Inc.
• Fujifilm Diosynth Biotechnologies
• Avid Bioservices Inc.
• BiOZEEN
• Nordmark Pharma GmbH
• Scorpius BioManufacturing Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 哺乳類細胞発酵技術市場2029：新たな機会を提供する国
• 哺乳類細胞発酵技術市場2029：新たな機会を提供するセグメント
• 哺乳類細胞発酵技術市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Mammalian cell fermentation technology refers to the process of cultivating mammalian cells under controlled conditions to produce biopharmaceuticals, vaccines, or other biological products. This technology involves optimizing cell growth and protein expression in bioreactors or fermenters, ensuring the production of high-quality and consistent yields of desired therapeutic proteins or substances.

The main types of mammalian cell fermentation technology include Chinese hamster ovary (CHO) cell fermentation, human embryonic kidney (HEK) cell fermentation, baby hamster kidney (BHK) cell fermentation, murine myeloma cell fermentation, and other types. Chinese hamster ovary (CHO) cell fermentation is a biotechnological process used in the production of therapeutic proteins, such as monoclonal antibodies and recombinant proteins. The various applications of mammalian cell fermentation technology include monoclonal antibodies, recombinant proteins, vaccines, hormones, enzymes, and other products. The end-users of this technology include biopharmaceutical companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and academic and research institutes.

The mammalian cell fermentation technology market research report is one of a series of new reports from The Business Research Company that provides mammalian cell fermentation technology market statistics, including mammalian cell fermentation technology industry global market size, regional shares, competitors with a mammalian cell fermentation technology market share, detailed mammalian cell fermentation technology market segments, market trends, and opportunities, and any further data you may need to thrive in the mammalian cell fermentation technology industry. This mammalian cell fermentation technology research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mammalian cell fermentation technology market size has grown rapidly in recent years. It will grow from $51.29 billion in 2024 to $57.48 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increased demand for biologics and biosimilars, increased focus on personalized medicine, increased output of biopharmaceuticals, and increased demand for scalable and effective cell culture methods.

The mammalian cell fermentation technology market size is expected to see rapid growth in the next few years. It will grow to $89.54 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to the increasing prevalence of chronic diseases, rising investments by multinational corporations, rising frequency of chronic diseases, increasing adoption of advanced bioprocessing techniques, increasing investment in research and development of novel recombinant proteins and growing demand for cancer therapies. Major trends in the forecast period include technological advancements in cell culture, technological advancements in bioreactor design, developing next-generation bioprocessing technologies, integration of multi-omics approaches, and technology-driven automation.

The increasing demand for biologics is anticipated to drive the growth of the mammalian cell fermentation technology market in the future. Biologics, which are medical products derived from living organisms or their components, are often used to treat diseases such as cancer, autoimmune disorders, and infectious diseases. The growing demand for biologics is driven by advancements in biotechnology, their effectiveness in treating prevalent chronic diseases, regulatory approvals, and increased investment in research and development. Mammalian cell fermentation technology is crucial for producing complex biologics, meeting the rising demand for personalized and targeted therapeutics. Its scalability, versatility, and ability to produce high-quality proteins foster innovation in the biopharmaceutical industry. For example, the National Library of Medicine reported in February 2024 that the Food and Drug Administration (FDA) approved 55 new drugs in 2023, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the growing demand for biologics is driving the expansion of the mammalian cell fermentation technology market.

Major companies in the mammalian cell fermentation technology market are focusing on developing innovative solutions, such as mammalian cell culture, to strengthen their market position. Mammalian cell culture is an essential tool in various fields, including biomanufacturing, research, and regenerative medicine, as it facilitates the production of therapeutic proteins, vaccines, and functional cells or tissue analogs. For example, in June 2024, Syntegon, a Germany-based biotechnology company, introduced its new Modular Bioprocessing Platform (MBP) at Achema 2024. This cutting-edge platform is designed to address key challenges in biopharmaceutical production. The MBP is a highly flexible, fully integrated, and automated solution capable of supporting a range of applications, including microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The modular design of the MBP allows for reduced lead times and costs while maintaining high functionality and quality, adhering to the rigorous "made in Germany" standard. Additionally, the platform's prefabricated cleanroom design places all peripheral technology outside the cleanroom, enhancing efficiency and simplifying maintenance, making it an advanced solution in the mammalian cell fermentation technology market.

In February 2024, Chrysea Limited, an Ireland-based biotechnology company, acquired Rodon Biologics from the Iberfar Group for an undisclosed amount. With this acquisition, Chrysea aims to strengthen its synthetic biology and biopharmaceutical development capabilities by integrating Rodon Biologics' expertise in protein engineering, cell-line development, precision fermentation, downstream processing, formulation, analytics, and production. Rodon Biologics, a Portugal-based manufacturer of biological products, operates in mammalian cell fermentation technology.

Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc

North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mammalian cell fermentation technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mammalian cell fermentation technology market consists revenues earned by entities by providing services such as cell line development, process development, cell culture and fermentation, analytical and quality control services, and formulation and fill-finish services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mammalian cell fermentation technology market also includes of sales of biosimilars, cell and gene therapy products, diagnostic enzymes and proteins, and therapeutic proteins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mammalian Cell Fermentation Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mammalian cell fermentation technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mammalian cell fermentation technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mammalian cell fermentation technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Chinese Hamster Ovary Cell Fermentation; Human Embryonic Kidney Cell Fermentation; Baby Hamster Kidney Cell Fermentation; Murine Myeloma Cell Fermentation; Other Types
• 2) By Application: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Hormones; Enzymes; Other Applications
• 3) By End-Use: Biopharmaceutical Companies; Contract Research Organizations And Contract Development and Manufacturing Organizations; Academic And Research Institutes
• Companies Mentioned: AbbVie Inc.; Thermo Fisher Scientific Inc; AstraZeneca PLC; Roche Holdings Inc.; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mammalian Cell Fermentation Technology Market Characteristics

3. Mammalian Cell Fermentation Technology Market Trends And Strategies

4. Mammalian Cell Fermentation Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Mammalian Cell Fermentation Technology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Mammalian Cell Fermentation Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Mammalian Cell Fermentation Technology Market Growth Rate Analysis
• 5.4. Global Mammalian Cell Fermentation Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Mammalian Cell Fermentation Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Mammalian Cell Fermentation Technology Total Addressable Market (TAM)

6. Mammalian Cell Fermentation Technology Market Segmentation

• 6.1. Global Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chinese Hamster Ovary Cell Fermentation
• Human Embryonic Kidney Cell Fermentation
• Baby Hamster Kidney Cell Fermentation
• Murine Myeloma Cell Fermentation
• Other Types
• 6.2. Global Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Hormones
• Enzymes
• Other Applications
• 6.3. Global Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Companies
• Contract Research Organizations And Contract Development and Manufacturing Organizations
• Academic And Research Institutes

7. Mammalian Cell Fermentation Technology Market Regional And Country Analysis

• 7.1. Global Mammalian Cell Fermentation Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Mammalian Cell Fermentation Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mammalian Cell Fermentation Technology Market

• 8.1. Asia-Pacific Mammalian Cell Fermentation Technology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mammalian Cell Fermentation Technology Market

• 9.1. China Mammalian Cell Fermentation Technology Market Overview
• 9.2. China Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mammalian Cell Fermentation Technology Market

• 10.1. India Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mammalian Cell Fermentation Technology Market

• 11.1. Japan Mammalian Cell Fermentation Technology Market Overview
• 11.2. Japan Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mammalian Cell Fermentation Technology Market

• 12.1. Australia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mammalian Cell Fermentation Technology Market

• 13.1. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mammalian Cell Fermentation Technology Market

• 14.1. South Korea Mammalian Cell Fermentation Technology Market Overview
• 14.2. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mammalian Cell Fermentation Technology Market

• 15.1. Western Europe Mammalian Cell Fermentation Technology Market Overview
• 15.2. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mammalian Cell Fermentation Technology Market

• 16.1. UK Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mammalian Cell Fermentation Technology Market

• 17.1. Germany Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mammalian Cell Fermentation Technology Market

• 18.1. France Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mammalian Cell Fermentation Technology Market

• 19.1. Italy Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mammalian Cell Fermentation Technology Market

• 20.1. Spain Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mammalian Cell Fermentation Technology Market

• 21.1. Eastern Europe Mammalian Cell Fermentation Technology Market Overview
• 21.2. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mammalian Cell Fermentation Technology Market

• 22.1. Russia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mammalian Cell Fermentation Technology Market

• 23.1. North America Mammalian Cell Fermentation Technology Market Overview
• 23.2. North America Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mammalian Cell Fermentation Technology Market

• 24.1. USA Mammalian Cell Fermentation Technology Market Overview
• 24.2. USA Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mammalian Cell Fermentation Technology Market

• 25.1. Canada Mammalian Cell Fermentation Technology Market Overview
• 25.2. Canada Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mammalian Cell Fermentation Technology Market

• 26.1. South America Mammalian Cell Fermentation Technology Market Overview
• 26.2. South America Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mammalian Cell Fermentation Technology Market

• 27.1. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mammalian Cell Fermentation Technology Market

• 28.1. Middle East Mammalian Cell Fermentation Technology Market Overview
• 28.2. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mammalian Cell Fermentation Technology Market

• 29.1. Africa Mammalian Cell Fermentation Technology Market Overview
• 29.2. Africa Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mammalian Cell Fermentation Technology Market Competitive Landscape And Company Profiles

• 30.1. Mammalian Cell Fermentation Technology Market Competitive Landscape
• 30.2. Mammalian Cell Fermentation Technology Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Roche Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Mammalian Cell Fermentation Technology Market Other Major And Innovative Companies

• 31.1. AGC Group
• 31.2. Lonza Group Ltd.
• 31.3. Boehringer Ingelheim GmbH
• 31.4. Catalent Inc.
• 31.5. Sartorius AG
• 31.6. Samsung Biologics Co. Ltd.
• 31.7. WuXi Biologics
• 31.8. Biocon Limited
• 31.9. Eppendorf AG
• 31.10. KBI Biopharma Inc.
• 31.11. Fujifilm Diosynth Biotechnologies
• 31.12. Avid Bioservices Inc.
• 31.13. BiOZEEN
• 31.14. Nordmark Pharma GmbH
• 31.15. Scorpius BioManufacturing Inc

32. Global Mammalian Cell Fermentation Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mammalian Cell Fermentation Technology Market

34. Recent Developments In The Mammalian Cell Fermentation Technology Market

35. Mammalian Cell Fermentation Technology Market High Potential Countries, Segments and Strategies

• 35.1 Mammalian Cell Fermentation Technology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Mammalian Cell Fermentation Technology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Mammalian Cell Fermentation Technology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer